Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.
Perez-Elias MJ, Garcia-Arota I, Muñoz V, Santos I, Sanz J, Abraira V, Arribas JR, González J, Moreno A, Dronda F, Antela A, Pumares M, Martí-Belda P, Casado JL, Geijos P, Moreno S; Realvirfen study group.
Perez-Elias MJ, et al. Among authors: moreno s, moreno a.
Antivir Ther. 2003 Dec;8(6):577-84.
Antivir Ther. 2003.
PMID: 14760891
Clinical Trial.